According to a new report published by K D Market Insights, titled, “Gene Expression Market Insights, Trends, Opportunity & Forecast, 2023–2032,” the global gene expression market size is anticipated to witness moderate growth during the forecast period i.e., 2023-2032. The increasing popularity of precision medicine and personalized treatment options, advancements in technology, growing demand for gene expression analysis in disease diagnosis and treatment, expansion of institutions and research centers in developing regions and increasing adoption of generation sequencing (NGS) technologies which are the major factors augmenting the growth of the global gene expression market. The global gene expression market is anticipated to grow at a high CAGR of 8.8% from 2023 to 2032. The market's revenue surged to $9.2 billion in 2022, and it is expected to further accelerate, reaching a notable $21.3 billion by 2032.
The increasing popularity of precision medicine and personalized treatment options, are further expected to create ample growth opportunities for the global gene expression market during the forecast period i.e., 2023-2032. Moreover, the advancements in technology have resulted in the creation of throughput and single cell gene expression analysis methods attracting the interest of researchers and healthcare professionals, has propelled market expansion. Rising adoption of gene expression analysis in drug discovery and development holds potential for growth, is expected to contribute towards the market growth during the period.
The North America region accounted for the largest share in the global gene expression market in 2022. The region is further projected to continue dominating in the market during the forecast period. This can be attributed to the well-established healthcare infrastructure, emphasis on precision medicine and personalized treatment options in healthcare.
According to products & services, the instruments segment accounted for the largest market share in the gene expression market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
The global gene expression market is segmented into products & services, end-users and region. Based on products & services, the market is bifurcated into consumables, instruments and services. Based on end-users, it is classified into pharma and biotech companies, research centers, others.
The global gene expression market is analyzed across North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa).
Key Insights of Gene Expression Market
- On the basis of products & services, the instruments segment accounted for the largest market share in the gene expression market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
- On the basis of region, North America accounted for the largest share in the global gene expression market in 2022. The region is further projected to continue dominating in the market during the forecast period.
- On the basis of region, Europe is estimated to account for the second largest share in the market during the forecast period.
Some of the major gene expression companies profiled in the report include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Roche, PerkinElmer, Qiagen, QIAGEN N.V., Oxford Gene Technologies, Eurofins Scientific.
Related Reports :-
https://www.kdmarketinsights.com/reports/pulmonary-embolism-treatment-market/7151
https://www.kdmarketinsights.com/reports/stomach-cancer-treatment-market/7148
https://www.kdmarketinsights.com/reports/systemic-mastocytosis-market/7147
